- Home
- MDCXW vs BRKRP Comparison
MDCXW vs BRKRP Comparison
Compare MDCXW & BRKRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDCXW | BRKRP |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2025 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MDCXW | BRKRP |
|---|---|---|
| Price | $0.33 | $422.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 636.0 | ★ 2.5K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $256.35 |
| 52 Week High | $1.45 | $474.99 |
Technical Indicators
Market Signals| Indicator | MDCXW | BRKRP |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 47.63 |
| Support Level | $0.31 | $401.31 |
| Resistance Level | $1.17 | $463.07 |
| Average True Range (ATR) | 0.07 | 6.74 |
| MACD | 0.00 | 0.62 |
| Stochastic Oscillator | 5.77 | 63.88 |
Price Performance
Historical ComparisonAbout MDCXW Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
About BRKRP Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.